--- title: "U.S. stock market update: Endra Life Sciences down 8.42%" description: "ENDRA Life Sciences fell 8.42%; GE HealthCare Tech fell 5.78%, with a transaction volume of USD 385 million; Intuitive Surgical rose 0.65%, with a transaction volume of USD 241 million; Penumbra rose " type: "news" locale: "en" url: "https://longbridge.com/en/news/250826736.md" published_at: "2025-07-30T15:23:05.000Z" --- # U.S. stock market update: Endra Life Sciences down 8.42% > ENDRA Life Sciences fell 8.42%; GE HealthCare Tech fell 5.78%, with a transaction volume of USD 385 million; Intuitive Surgical rose 0.65%, with a transaction volume of USD 241 million; Penumbra rose 12.88%, with a transaction volume of USD 152 million; Abbott rose 0.59%, with a market value of USD 224 billion **U.S. Stock Market Midday Update** Endra Life Sciences fell 8.42%, with increased trading volume. Based on recent key news: 1. On June 27, Guangkang Biochemical had a block trade at a 2.3% discount, with 1.48 million shares traded, leading to a lack of confidence in the biotechnology sector, affecting Endra Life Sciences' stock price. 2. On June 9, Sanyuan Biotech had a block trade at a 1% discount, weakening market confidence in the biotechnology sector, impacting Endra Life Sciences' stock price. 3. On June 4, Rejane Biotech had a block trade at a 14.17% discount, further weakening market confidence in the biotechnology sector, affecting Endra Life Sciences' stock price. **Top Stocks by Industry Trading Volume** GE HealthCare Tech fell 5.78%, with increased trading volume. Based on recent important news: 1. On July 30, GE HealthCare announced its second-quarter earnings report, and although earnings per share exceeded expectations, the adjusted core profit margin fell by 80 basis points due to tariff impacts, leading to a 5.78% drop in stock price. 2. On July 30, J.P. Morgan analysts pointed out that while the company's outlook is good, conservative tariff assumptions may affect future growth, leading to negative market reactions. 3. On July 30, despite growth in various business segments, imaging equipment revenue only grew by 2%, failing to boost market confidence. Intuitive Surgical rose 0.65%, with increased trading volume. Based on recent important news: 1. On July 29, Intuitive Surgical's Executive Chairman Gary S. Guthart reported selling company common stock, attracting market attention, and the stock price rose 0.65%. 2. On July 29, Intuitive Surgical faces competitive threats, but its business condition is better than recent stock performance, leading to an optimistic market outlook. 3. On July 27, market analysts did not include Intuitive Surgical in their recommended list, despite its rating being a moderate buy, affecting market confidence. Penumbra rose 12.88%, with increased trading volume. Based on recent important news: 1. On July 29, Penumbra reported Q2 net income of $45.27 million, with a full-year revenue outlook of $1 billion, driving the stock price up by 12.88%. 2. On July 30, UBS raised Penumbra's target price to $335, further boosting market confidence. 3. On July 30, Penumbra expects a 20% to 21% growth in U.S. thrombectomy procedures, enhancing investor confidence in the company's future growth. **Top Stocks by Industry Market Capitalization** Abbott rose 0.59%, with increased trading volume. Based on recent important news: 1. On July 29, Abbott plans to significantly increase stock buybacks due to robust second-quarter performance, driving the stock price up by 0.59% 2. On July 28, the global diagnostic testing market report was released, indicating future growth potential and boosting investor confidence. 3. On July 27, retail trading was active, driving an overall increase in market trading volume ### Related Stocks - [NDRA.US - Endra Life Sciences](https://longbridge.com/en/quote/NDRA.US.md) ## Related News & Research | Title | Description | URL | |-------|-------------|-----| | Yijia Group Corp. Becomes VitaNova Life Sciences | Yijia Group Corp. has officially changed its name to VitaNova Life Sciences Corporation, as per a recent SEC filing. The | [Link](https://longbridge.com/en/news/273895310.md) | | ENDRA Life Sciences Inc. Announces Date for Upcoming Annual Stockholder Meeting | ENDRA Life Sciences Inc. will hold its 2025 Annual Meeting of Stockholders on December 9, 2025. Stockholders will vote t | [Link](https://longbridge.com/en/news/261682293.md) | | ENDRA Life Sciences Announces $14.4 Million Private Placement to Launch Digital Asset Treasury Strategy Managed by Arca | ENDRA Life Sciences Inc. has announced a private placement of up to $14.4 million to launch a digital asset treasury str | [Link](https://longbridge.com/en/news/261274197.md) | | ENDRA Life Sciences Reports TAEUS Device Matches MRI Accuracy in Liver Disease Study | ENDRA Life Sciences Inc. announced that its TAEUS® Liver device closely matches MRI accuracy in detecting liver fat frac | [Link](https://longbridge.com/en/news/268613978.md) | | ENDRA Life Sciences Reports Positive Feasibility Study Results for TAEUS Liver Fat Quantification Device | ENDRA Life Sciences announced positive preliminary results from a feasibility study of its TAEUS Liver device for quanti | [Link](https://longbridge.com/en/news/266749309.md) | --- > **Disclaimer**: This article is for reference only and does not constitute any investment advice.